Costco Weight-Loss Program: Omission of Critical Data Puts Patients at (Financial) Risk

This week, the world learned that Costco Wholesale would start selling Novo Nordisk ' s newest, but vastly overpriced GLP-1 inhibitor medicine known generically as semaglutide (sold under the brand names Ozempic and Rybelsus for Type 2 diabetes, and under the brand name of Wegovy for weight-loss for those with obesity without Type 2 diabetes). We learned of the Costco GLP-1 initiative from a press release from Costco ' s strategic partner known as Sesamehttps://sesamecare.com/ which is the entity which will connect patients with its network of thousands of outpatient healthcare providers nationwide who are more than willing to prescribe GLP-1 inhibitors as weight-loss drugs with barely an examination (see the press release athttps://www.globenewswire.com/news-release/2024/04/02/2856203/0/en/Wholesale-Weight-Loss-Sesame-Unveils-Specialized-Care-for-Weight-Loss-with-Pricing-Exclusively-for-Costco-Members.html for more). The two companies have a dedicated Costco Weight-Loss Program website athttps://www.CostcoWeightLoss.com/. But having a doctor willing to prescribe the overpriced drugs online or over the telephone certainly makes it easier for patients to get the overpriced weight-loss drugs.I keep mentioning that that semaglutide is vastlyoverpriced because it is. Little new science, but ever-so-slight improvements on the original molecule. But readers need to understand that a whole bunch of cheaper biosimilars of liraglutide are right now currently pending FDA approval ...
Source: Scott's Web Log - Category: Endocrinology Tags: 2024 biosimilars Costco GLP-1 inhibitor liraglutide semaglutide Sesame Source Type: blogs